Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8796443 Reduced size self-delivering RNAi compounds

Patent 8796443 was granted and assigned to Rxi Pharmaceuticals Corporation on August, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

Rxi Pharmaceuticals Corporation

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

87964430

Patent Inventor Names

Dmitry Samarsky0

Anastasia Khvorova0

James Cardia0

Joanne Kamens0

Tod M. Woolf0

William Salomon0

Date of Patent

August 5, 2014

Patent Application Number

131203420

Date Filed

September 22, 2009

Patent Citations Received

‌

US Patent 12077755 Bioactive conjugates for oligonucleotide delivery

‌

US Patent 11667915 RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality

‌

US Patent 11767527 Modified oligonucleotides targeting SNPs

‌

US Patent 11712478 Compositions and methods of treating muscle atrophy and myotonic dystrophy

‌

US Patent 11753638 Conjugated oligonucleotides

‌

US Patent 12104156 Compositions and methods of treating facioscapulohumeral muscular dystrophy

...

Patent Primary Examiner

‌

Jennifer McDonald

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8796443 Reduced size self-delivering RNAi compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API